Learn More
Medchemexpress LLC 1-(dibenzylamino)-3-(4-(trifluoromethyl)phenoxy)propan-2-ol | 2222094-18-8 | 99.7% | C24H24F3NO2 | 10MG

Supplier: Medchemexpress LLC HY13465610MG
BC1618 is a small-molecule research compound that inhibits Fbxo48 and stimulates AMPK-dependent signaling by preventing pAMPKα degradation. It is used in preclinical studies of mitophagy, mitochondrial dynamics, and metabolic regulation.
- Orally active tool compound suitable for in vivo studies.
- Stimulates AMPK-dependent signaling by preventing pAMPKα degradation.
- Facilitates research into mitophagy, mitochondrial fission, and insulin sensitivity.
- High reported purity for reliable experimental results.
- Soluble in DMSO, insoluble in water, enabling formulation flexibility.
- Available in small quantities suitable for biochemical and animal studies.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.